Merck KGaA (OTCMKTS:MKKGY) Sees Unusually-High Trading Volume – Time to Buy?

Posted by Patrick Bannon on Sep 14th, 2026

Merck KGaA (OTCMKTS:MKKGY – Get Free Report) shares saw strong trading volume on Monday . 270,223 shares traded hands during trading, an increase of 197% from the previous session’s volume of 91,034 shares.The stock last traded at $30.06 and had previously closed at $30.46.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on MKKGY. UBS Group downgraded shares of Merck KGaA from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 20th. Jefferies Financial Group assumed coverage on shares of Merck KGaA in a research note on Tuesday, May 26th. They set a “hold” rating on the stock. HSBC upgraded Merck KGaA to a “hold” rating in a research note on Monday, July 6th. Finally, Zacks Research lowered Merck KGaA from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 20th. Six analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company presently has an average rating of “Hold”.

Check Out Our Latest Stock Analysis on MKKGY

Merck KGaA Stock Down 0.9%

The firm has a market cap of $19.51 billion, a price-to-earnings ratio of 15.56, a PEG ratio of 2.86 and a beta of 0.96. The business has a fifty day simple moving average of $32.15 and a 200 day simple moving average of $29.58. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.51 and a quick ratio of 1.00.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA is a Germany-based science and technology company headquartered in Darmstadt. Founded in 1668, it is one of the world’s oldest pharmaceutical and chemical businesses. Merck KGaA operates independently from the U.S.-based Merck & Co, Inc, which uses the name MSD in markets outside the United States and Canada.

The company operates through three primary business sectors: Life Science, Healthcare and Electronics. Its Life Science business supplies laboratory products, research tools, bioprocessing equipment and services used by academic institutions, pharmaceutical manufacturers and other industrial customers.